The add-on effect of dengzhan shengmai capsules on secondary prevention of ischemic stroke: A multicentre, randomised, placebo-controlled clinical trial
Yefeng Cai(Southern Medical University), Shaohong Chen(Chengdu University of Traditional Chinese Medicine), Lixin Wang(Hebei North University), Xiaojia Ni(Guangzhou University of Chinese Medicine), Yan Huang(Guangzhou University of Chinese Medicine), Aihua Ou(Guangzhou University of Chinese Medicine), Jianwen Guo(Guangzhou University of Chinese Medicine), Xiaoyun Zhang(Chengdu University of Traditional Chinese Medicine), Min Zhao(Southern Medical University), Weixiong Liang(Guangzhou University of Chinese Medicine), Baili Yu(Chengdu University of Traditional Chinese Medicine), Jingbo Sun(Guangzhou University of Chinese Medicine)
Cited by 16
Related Papers
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
|New England Journal of Medicine|2021|742
The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage
|Frontiers in Immunology|2023|335
Polymerization Induced Self-Assembly of a Site-Specific Interferon α-Block Copolymer Conjugate into Micelles with Remarkably Enhanced Pharmacology
|Journal of the American Chemical Society|2018|97
Bibliometric and Visual Analysis of Research on the Links Between the Gut Microbiota and Depression From 1999 to 2019
|Frontiers in Psychiatry|2021|90
p300 plays a role in p16INK4a expression and cell cycle arrest
|Oncogene|2007|79